Goldenberg G J, Lee M, Lam H Y, Begleiter A
Cancer Res. 1977 Mar;37(3):755-60.
Mechanism of transport of the alkylating agent [14C]melphalan was investigated in L5178Y lymphoblasts in vitro. A time course of melphalan uptake was approximately linear for 5 to 10 min and thereafter entered a plateau region. Evidence that unidirectional influx of melphalan is carrier mediated was that uptake obeyed simple Michaelis-Menten kinetics, that it demonstrated chemical specificity, and that the cell/medium distribution ratio of drug decreased with increasing extracellular drug concentration. The kinetic parameters for melphalan transport consisted of a Km (mean +/- S.E.) of 1.53 +/- 0.18 X 10(-4) M and a transport capacity (Vmax) of 3.48 +/- 0.31 X 10(-17) mole/min/cell. Findings suggesting that transport was at least in part energy dependent and not simply a passive process were that drug uptake was temperature sensitive and sodium dependent. Analysis of cell sap constituents indicated the presence of intact drug within the cell. The percentage of radioactivity (mean +/- S.D.) found in the cell sap fraction was 95.8 +/- 2.2% of total cell activity, and 92.6 +/- 4.1% of this was trichloroacetic acid soluble. Thin-layer chromatography of the cell sap fraction and medium each revealed that the majority of radioactivity migrated as a single peak with an RF value identical with that obtained for free drug. The alkylating potential of intact drug complicated interpretation of the finding of apparent uphill transport against a concentration gradient. This observation, together with the relatively low cell-medium ratio (mean +/- S.D.) of 3.07 +/- 1.07, favors the concept that melphalan transport occurs by a facilitated diffusion process, although an active transport system has not been entirely excluded. The relative insensitivity of melphalan uptake to a wide range of metabolic inhibitors also suggests that transport is by a facilitated diffusion mechanism rather than an active process. Other alkylating agents and several amino acids including the L and D isomers of phenylalanine did not inhibit melphalan transport; thus a native substrate was not identified for the melphalan carrier and transport was by a mechanism separate from that of other alkylating agents.
在体外研究了烷化剂[14C]美法仑在L5178Y淋巴母细胞中的转运机制。美法仑摄取的时间进程在5至10分钟内大致呈线性,此后进入平台期。美法仑单向流入是载体介导的证据包括:摄取遵循简单的米氏动力学,具有化学特异性,并且药物的细胞/培养基分布比随细胞外药物浓度的增加而降低。美法仑转运的动力学参数包括Km(平均值±标准误)为1.53±0.18×10−4 M,转运能力(Vmax)为3.48±0.31×10−17摩尔/分钟/细胞。表明转运至少部分依赖能量而非简单被动过程的发现包括:药物摄取对温度敏感且依赖钠。细胞液成分分析表明细胞内存在完整的药物。在细胞液部分中发现的放射性百分比(平均值±标准差)为细胞总活性的95.8±2.2%,其中92.6±4.1%可溶于三氯乙酸。细胞液部分和培养基的薄层色谱分析均显示,大部分放射性以单峰形式迁移,其RF值与游离药物的RF值相同。完整药物的烷化潜力使对逆浓度梯度的明显上坡转运这一发现的解释变得复杂。这一观察结果,连同相对较低的细胞-培养基比(平均值±标准差)3.07±1.07,支持了美法仑转运通过易化扩散过程发生的概念,尽管尚未完全排除主动转运系统。美法仑摄取对多种代谢抑制剂相对不敏感也表明转运是通过易化扩散机制而非主动过程。其他烷化剂和几种氨基酸,包括苯丙氨酸的L和D异构体,均不抑制美法仑转运;因此,未鉴定出美法仑载体的天然底物,且转运是通过与其他烷化剂不同的机制进行的。